Nuzenio

Evotec

Evotec news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Evotec's AI Alliance Faces a Market That's Already Made Up Its Mind - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 14:33:14 GMT Evotec AG (NASDAQ:EVO) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeatMarketBeat · Sat, 08 Aug 2026 08:15:49 GMT Evotec and Odyssey collaborate on AI-enabled R&D - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 18:22:21 GMT Evotec and Odyssey Therapeutics enter AI-enabled drug discovery collaboration in autoimmune and inflammatory diseases - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMT Odyssey embarks on AI-driven drug discovery journey with Evotec - FirstWord PHARMAFirstWord PHARMA · Thu, 06 Aug 2026 19:16:57 GMT Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases - Contract PharmaContract Pharma · Thu, 06 Aug 2026 19:16:38 GMT Evotec partners with Odyssey Therapeutics on AI-enabled autoimmune, inflammatory drug discovery - BitgetBitget · Thu, 06 Aug 2026 12:18:25 GMT EVO Looks 51.5% Undervalued on GF Value™ Despite Autoimmune Drug Partnership - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:18:11 GMT

Timeline

Sat, 08 Aug 2026 14:33:14 GMTEvotec's AI Alliance Faces a Market That's Already Made Up Its Mind - AD HOC NEWS

Sat, 08 Aug 2026 08:15:49 GMTEvotec AG (NASDAQ:EVO) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Fri, 07 Aug 2026 18:22:21 GMTEvotec and Odyssey collaborate on AI-enabled R&D - Pharmaceutical Technology

Fri, 07 Aug 2026 10:18:54 GMTEvotec and Odyssey Therapeutics enter AI-enabled drug discovery collaboration in autoimmune and inflammatory diseases - The Pharma Letter

Thu, 06 Aug 2026 19:16:57 GMTOdyssey embarks on AI-driven drug discovery journey with Evotec - FirstWord PHARMA

Thu, 06 Aug 2026 19:16:38 GMTEvotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases - Contract Pharma

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

EVO6 live mentions Odyssey Therapeutics6 live mentions Autoimmune6 live mentions NASDAQ4 live mentions Inflammatory Diseases4 live mentions Enabled R4 live mentions D Collaboration4 live mentions Advance Preclinical Development4 live mentions Odyssey3 live mentions The Pharma Letter3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Evotec.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.